The Advisory Board serves in an advisory capacity to the Center's Director. Board members’ duties include fundraising, public speaking, and other public relations activities to advance public awareness of successful adult, cord blood and related stem three cell therapeutic options. The Board is required to meet at least four times each year and will be authorized to meet upon the call of the chairperson.

The Center’s director serves as an ex officio member of the Board. Advisory Board members may serve for only three consecutive terms and its members will serve without compensation. The bill provides for Board vacancies and appointments of successor members. The Governor will appoint the Board chairperson.

Roy Jensen
Chair, Midwest Stem Cell Therapy Center Advisory Board
Vice Chancellor and Director, The University of Kansas Cancer Center

Representative Dan Hawkins
Representative, State of Kansas
Chair, Health and Human Services
Vice Chair, Home and Community Based Services Oversight

Sunil Abhyankar, M.D.
Professor of Medicine
Director of Midwest Stem Cell Therapy Center
Medical Director - Pheresis and Cell Processing
Division of Hematologic Malignancies and Cellular Therapeutics

Bassam Mattar, M.D., FACP
Clinical Professor, Program Director of Transplant and Cell Therapy Center of Kansas, Wichita

Matthias Salathe, M.D.
Chair, Internal Medicine
School of Medicine

James L. Sherley, M.D., Ph.D.
President and CEO
Asymmetrex, LLC

Senator Mike Thompson
Senator, State of Kansas
Senate Public Health and Welfare Committee

Hans Coetzee, Ph.D.
Head, Department of Anatomy & Physiology, College of Veterinary Medicine, K-State University

Scott Weir, Pharm D, Ph.D.
Professor of Clinical Pharmacology
Director, Institute for Advancing Medical Innovation, KU Medical Center
Assoc Director, Translational Research, University of Kansas Cancer Center

Weijing Sun, M.D., FACP
Division Director Medical Oncology
School of Medicine